Eiken Chemical Co., Ltd. (TYO:4549)
2,439.00
+14.00 (0.58%)
Dec 8, 2025, 3:30 PM JST
Eiken Chemical Revenue
Eiken Chemical had revenue of 10.23B JPY in the quarter ending September 30, 2025, with 0.23% growth. This brings the company's revenue in the last twelve months to 41.24B, up 4.36% year-over-year. In the fiscal year ending March 31, 2025, Eiken Chemical had annual revenue of 40.54B with 1.22% growth.
Revenue (ttm)
41.24B
Revenue Growth
+4.36%
P/S Ratio
1.95
Revenue / Employee
58.75M
Employees
702
Market Cap
80.41B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 40.54B | 487.00M | 1.22% |
| Mar 31, 2024 | 40.05B | -3.22B | -7.44% |
| Mar 31, 2023 | 43.27B | 275.00M | 0.64% |
| Mar 31, 2022 | 43.00B | 4.33B | 11.20% |
| Mar 31, 2021 | 38.67B | 2.08B | 5.69% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.42T |
| Otsuka Holdings | 2.42T |
| Astellas Pharma | 2.01T |
| Daiichi Sankyo Company | 1.98T |
| Chugai Pharmaceutical | 1.21T |
| Terumo | 1.06T |
| Olympus | 977.65B |
| HOYA Corporation | 892.50B |
Eiken Chemical News
- 4 weeks ago - Eiken Chemical Co., Ltd. 2026 Q2 - Results - Earnings Call Presentation - Seeking Alpha